Salivary gland squamous cell carcinoma

MONDO:0044740

A squamous cell carcinoma arising from the salivary glands. The majority of patients are in their sixth through eight decades. It usually presents as a rapidly enlarging mass, which may be painful. It usually has an aggressive clinical course.

Also known as: SCC of salivary gland, SCC of the salivary gland, epidermoid carcinoma of salivary gland, epidermoid carcinoma of the salivary gland, saliva-secreting gland squamous cell carcinoma, salivary gland SCC, salivary gland epidermoid carcinoma, salivary gland squamous cell cancer

2971 clinical trials for this condition and its sub-types, 4 tagged with Salivary gland squamous cell carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Oral cavity squamous cell carcinoma (154) ↑ Salivary gland carcinoma (36) ↑ Malignant epithelial tumor of salivary glands (4)

Sub-types of Salivary gland squamous cell carcinoma

Parotid gland squamous cell carcinoma 0 trials
Salivary gland adenosquamous carcinoma 0 trials

Including sub-types (2971) Tagged with Salivary gland squamous cell carcinoma (4)

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New hope for rare cancer: targeted drug afatinib tested in fanconi anemia patients

Disease control Recruiting now

This study tests a drug called afatinib in 25 adults with Fanconi anemia who have advanced head and neck cancer that cannot be removed by surgery. Afatinib is a pill that blocks a protein helping cancer grow. The goal is to see if it can shrink tumors and control the disease. Res…

Phase 1/2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC

Salivary gland squamous cell carcinoma

Where it sits in the disease tree

New hope for rare cancer: targeted drug afatinib tested in fanconi anemia patients